Stockscreener 앱 받기
0.1964
9.62%
-0.0209
시간 외 거래:
.20
0.0036
+1.83%
전일 마감가:
$0.2173
열려 있는:
$0.22
하루 거래량:
2.51M
Relative Volume:
0.17
시가총액:
$6.63M
수익:
-
순이익/손실:
$-18.35M
주가수익비율:
-0.1693
EPS:
-1.16
순현금흐름:
$-19.20M
1주 성능:
-11.21%
1개월 성능:
-27.61%
6개월 성능:
-59.06%
1년 성능:
-83.36%
1일 변동 폭
$0.1945
$0.22
1주일 범위
$0.1945
$0.2359
52주 변동 폭
$0.1945
$2.08
Theriva Biologics Inc Stock (TOVX) Company Profile
명칭
Theriva Biologics Inc
전화
301 417 4364
주소
9605 Medical Center Drive, Suite 270, Rockville
TOVX을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
TOVX
Theriva Biologics Inc
|
0.1964 | 7.33M | 0 | -18.35M | -19.20M | -1.16 |
|
VRTX
Vertex Pharmaceuticals Inc
|
455.71 | 114.69B | 11.74B | 3.68B | 3.34B | 14.19 |
|
REGN
Regeneron Pharmaceuticals Inc
|
752.62 | 77.91B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ARGX
Argen X Se Adr
|
850.95 | 54.05B | 3.06B | 1.28B | 447.35M | 19.67 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
391.50 | 52.52B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
INSM
Insmed Inc
|
196.92 | 42.02B | 447.02M | -1.18B | -906.14M | -6.1812 |
Theriva Biologics Inc 주식(TOVX)의 최신 뉴스
Why Theriva Biologics Inc. stock is a strong buy call2025 Analyst Calls & AI Driven Stock Reports - Newser
Can Theriva Biologics Inc. (SFY0) stock test all time highs2025 Market Overview & Verified Swing Trading Watchlists - Newser
Why Theriva Biologics Inc. stock gets analyst attention2025 Institutional Moves & Weekly Top Performers Watchlists - Newser
How Theriva Biologics Inc. (SFY0) stock reacts to Fed tightening2025 Market Overview & Smart Investment Allocation Insights - Newser
Will Theriva Biologics Inc. stock outperform foreign stocksTake Profit & Daily Profit Focused Stock Screening - Newser
Will Theriva Biologics Inc. stock maintain strong growthQuarterly Earnings Summary & Fast Gain Stock Trading Tips - Newser
Can Theriva Biologics Inc. stock reach $200 price targetJuly 2025 Fed Impact & AI Optimized Trading Strategy Guides - Newser
Will Theriva Biologics Inc. stock beat value stocksMarket Movers & Growth Focused Stock Pick Reports - Newser
Theriva Biologics (NYSE: TOVX) files resale for 16,184,560 warrant shares - Stock Titan
Can Theriva Biologics Inc. stock deliver consistent EPS growthPortfolio Return Report & Low Drawdown Trading Techniques - Newser
Will Theriva Biologics Inc. stock top growth indexesTrade Exit Summary & Safe Entry Zone Identification - Newser
Will Theriva Biologics Inc. stock outperform benchmarks2025 Market Overview & Weekly High Return Opportunities - Newser
How Theriva Biologics Inc. stock reacts to monetary easingJuly 2025 Market Mood & AI Forecasted Stock Moves - Newser
Risks Report: Will Theriva Biologics Inc SFY0 stock draw ESG focused fundsWeekly Trade Recap & Accurate Entry and Exit Point Alerts - BỘ NỘI VỤ
Healthy Upside Potential: Theriva Biologics Inc (TOVX) - Setenews
Why Theriva Biologics Inc. stock appeals to dividend investors2025 Market WrapUp & Reliable Volume Spike Alerts - moha.gov.vn
Is Theriva Biologics Inc. stock supported by strong fundamentals2025 Volume Leaders & Weekly High Return Stock Forecasts - moha.gov.vn
EPS Watch: Why Theriva Biologics Inc. stock appeals to dividend investorsJuly 2025 News Drivers & Growth Focused Entry Point Reports - BỘ NỘI VỤ
What market sentiment indicators show for Theriva Biologics Inc. (SFY0) stockEarnings Growth Report & Technical Confirmation Alerts - moha.gov.vn
Theriva Biologics, Inc. (TOVX) 6.8% in After-hours: Despite No Clear Catalyst - Stocks Telegraph
Theriva Biologics (NYSEAMERICAN:TOVX) Trading 3.4% Higher – Still a Buy? - Defense World
Views of Wall Street’s Leading Experts on Theriva Biologics Inc - Setenews
What drives Theriva Biologics Inc stock priceGeopolitical Risk Analysis & Breakthrough Profit Margins - earlytimes.in
TOVX SEC FilingsTHERIVA BIOLOGICS INC 10-K, 10-Q, 8-K Forms - Stock Titan
TOVX 10-Q及美國證券交易委員會申報文件 - Yahoo 財經
How Theriva Biologics Inc. (SFY0) stock reacts to new regulationsJuly 2025 Chart Watch & Risk Controlled Daily Trade Plans - newser.com
How Theriva Biologics Inc. stock responds to policy changes2025 Technical Patterns & Risk Controlled Daily Trade Plans - newser.com
Is Theriva Biologics Inc. (SFY0) stock a top pick for value investors - newser.com
Is Theriva Biologics Inc. (SFY0) stock overpriced at current multiplesJuly 2025 Decliners & Stepwise Swing Trade Plans - newser.com
Can Theriva Biologics Inc. recover in the next quarterJuly 2025 Institutional & Growth Focused Entry Reports - newser.com
How Theriva Biologics Inc. (SFY0) stock responds to bond marketJuly 2025 Analyst Calls & Weekly High Momentum Picks - newser.com
Theriva Biologics Inc (TOVX) 재무 분석
매출
순이익
현금흐름
주당 순 이익
0.36%
1.12%
자본화:
|
볼륨(24시간):